University of Colorado Boulder researchers have discovered a brain signature that identifies fibromyalgia sufferers with 93 percent accuracy, a potential breakthrough for future clinical diagnosis and treatment of the highly prevalent condition.
Fibromyalgia is commonly defined as chronic widespread musculoskeletal pain accompanied by symptoms such as fatigue, anxiety and mood disorders. The Centers for Disease Control and Prevention (CDC) estimates that fibromyalgia affects more than five million adults annually in the U.S., with significantly higher occurrence rates in women than in men.
Historically, fibromyalgia has been difficult to diagnose and treat due to a lack of a well-categorized tissue pathology and symptoms that overlap with other common chronic illnesses.
CU Boulder researchers used functional MRI scans (fMRI) to study brain activity in a group of 37 fibromyalgia patients and 35 control patients as they were exposed to a variety of non-painful visual, auditory and tactile cues as well as painful pressure.
Read the full article: Neural signature for fibromyalgia may aid diagnosis, treatment
Share this entry
- Valeria Robinson-Baker, B.S.Pharm., R.Ph., C.Ph., is Appointed to the American Health Council’s Industry Board September 18, 2018
- The American Health Council Names Norman Tomaka, BS, Pharm.MS, FAPhA to its Industry Board September 10, 2018
- Samuel Ashu, Pharm.D., is Elected to the American Health Council’s Industry Board September 7, 2018
- Erin Engel, DPM is Appointed to the American Health Council’s Board of Physicians August 28, 2018
- Brittany Bento, PA-C is Appointed to the American Health Council’s Board of Physicians August 27, 2018
- The American Health Council Welcomes Kathleen Mau, DNP, APRN, ACCNS-AG, ACNS-BC, CEN to its Board of Nurses August 22, 2018